INTRODUCTION
prevalence of cardiovascular circulatory diseases has risen by 31% contributing to over 15,616,000 deaths worldwide in the year 2010 [2] . Specifically with the prevalence of cardiomyopathies rising by 40%, early diagnosis is critical in directing treatment and following progression of the disease [2, 3] .
Given nonspecific symptoms and baseline tests, noninvasive imaging with echocardiography, cardiac magnetic resonance imaging (CMRI) and positron emission tomography (PET)-computed tomography (CT) performed with fluorine-18-fluoro-deoxyglucose (FDG-PET-CT) is instrumental [1] . This report describes a case of cardiac sarcoidosis focusing on workup that led to the diagnosis. It also gives an overview of three of the most common cardiomyopathies: amyloidosis, myocarditis, and sarcoidosis and their workup with various imaging modalities namely echocardiography, CMRI, and FDG-PET.
The analysis in this article is based on previously conducted studies, and does not involve any new studies with human or animal subjects performed by any of the authors.
CASE REPORT
A 43-year-old Caucasian man with history of premature ventricular contractions (PVCs) and mild-moderate left ventricular (LV) systolic dysfunction with normal LV dimensions on echocardiogram performed at an outside institution was admitted from the clinic after a second opinion with a chief complaint of increasing palpitations over a period of 2 months. The patient did not smoke, denied chest discomfort, shortness of breath with daily activities, paroxysmal nocturnal dyspnea, and orthopnea. There was no history of hypertension, dyslipidemia, coronary artery disease (CAD), and no family history of premature CAD or stroke. The patient also did not have a recent history of severe illness, respiratory or otherwise, or travel outside of the United States.
On physical examination, the patient appeared physically fit in no apparent distress.
The vital signs were temperature 97.8 F, blood pressure 137/71 mmHg, heart rate 45 beats/min (bpm), respiratory rate 18 breathes/minute, and oxygen saturation 100% on room air. There was no jugular venous distention and no carotid bruits. Lungs were clear to auscultation. Palpation of the heart was unremarkable. The heart rate was regular with an occasional premature beat. The first and second heart sounds were normal, and no murmurs, rubs, or gallops were appreciated. 
Imaging
Noninvasive imaging techniques play a critical role in screening and diagnosing these diseases [1] . Echocardiography is a widely available noninvasive imaging technique; however, it has limited specificity in diagnosing infiltrative and inflammatory cardiomyopathies [5] .
Although morphologic and functional features of the heart in restrictive cardiomyopathy can [5] .
For inflammatory diseases and cardiomyopathy, more specific cross-sectional tissue imaging is required [1] . CMRI has proven to be instrumental in the diagnosis of myocardial and pericardial diseases due to its noninvasiveness, lack of radiation, tomographic imaging, reproducibility, and high spatial resolution [6] .
PET-CT can identify an inflammatory process even before structural changes are apparent on CT scanning [7] . PET performed with FDG identifies metabolically active tissue and complements the cross-sectional imaging modalities that provide anatomical features [7] . When patients present with nonspecific symptoms that are difficult to evaluate with routine imaging modalities, whole body imaging with FDG-PET-CT becomes instrumental [7] .
Amyloidosis
Systemic amyloidosis results from deposition of misfolded, insoluble protein throughout the body [8] . Cardiac amyloidosis is common in immunoglobulin amyloid light-chain (AL) and transthyretin (TTR) types of amyloidosis. It is caused by deposition of glycoproteins in myocardial interstitium [8] . This leads to concentric thickening of the myocardium and impaired contractility and diastolic dysfunction with restrictive features which in turn can lead to arrhythmias and sudden death [6, 8, 9] . Diagnosis is made by positive endomyocardial biopsy or biopsy of any other organ combined with typical features on cardiac imaging [1] . The mainstay of treatment of amyloidosis is supportive, with use of high-dose diuretics for heart failure that results from restrictive pathophysiology [10] . Given the high rates of and prophylactic antiarrhythmics; however, there are limited data that demonstrate efficacy of these interventions [10] . In AL amyloidosis, chemotherapy has been shown to enhance survival [10] . For TTR amyloidosis, liver transplantation is the standard treatment to remove the main source of plasma TTR [10] .
Two-dimensional echocardiography (2D echo) can be used to assess structural anatomy and LV function in cardiac amyloid [11] .
Usually all four chambers are involved and thickening of the inter-atrial septum and right atrial free wall is highly specific for amyloidosis [12] . Features suggestive of amyloidosis on 2D echo are thickened myocardium (from amyloid deposition in the interstitial space) with increased myocardial echogenicity and granular speckling [12] . One study compared patients with documented cardiac amyloidosis with controls noting that presence of LV hypertrophy corresponds with sensitivity of 87% and specificity of 81% when increased echogenicity is observed [12] . The specificity rose to 100% if increased atrial thickness was also present [12] . Other features that may also be present include thickened RV myocardium, decreased ventricular cavity size, bi-atrial enlargement, and the presence of pericardial effusion [11] , findings more often present in advanced disease. [9] . MIBG is an analogue of a neurotransmitter which accumulates in nerve endings and assesses sympathetic nerve activity [9] . MIBG uptake is recorded early at 15 min and later at 4 h (delayed) to assess distribution of sympathetic innervation and degree of impairment of sympathetic nerve impairment [9] . A decrease in MIBG accumulation correlates with severity of amyloid accumulation in patients with familial amyloid polyneuropathy [15] . Although PET tracers show promise by providing better myocardial-sympathetic nervous system innervation, resolution and quantification, thus far no PET tracers specific for amyloidosis have been identified. FDG is not ideal for imaging amyloidosis since it is a metabolic tracer and does not bind to amyloid protein [9] . CMRI is effective in detecting early stages of amyloidosis [10] . The typical features of cardiac amyloidosis such as increased LV wall thickness, bi-atrial enlargement, and pericardial effusions, are well imaged with CMRI [8] . Late gadolinium enhancement and gadolinium kinetics are also useful in assessing severity of amyloid burden and predicting mortality [8] . Delayed enhancement can also be seen in imaging due to increased retention of contrast by expansion of the interstitial space in the amyloid rich area [8] . This results in a classic diffuse, global subendocardial delayed enhancement pattern in a nonvascular distribution [8] . This diffuse heterogeneous enhancement along with biventricular subendocardial enhancement leads to a striped appearance seen in cardiac amyloidosis [6] . Expansion of the extracellular volume can be well imaged with CMRI and has been recently proposed as an early feature of cardiac amyloidosis [16, 17] .
Myocarditis
Myocarditis is an acute or chronic inflammation of myocardium caused by a variety of processes including infections, systemic diseases, drugs, or toxins [1, 18] . Most patients are asymptomatic; however, chest pain, arrhythmias, and rapid onset heart failure have been documented [1] . Furthermore, myocarditis is a major cause of sudden death in adults \40 years of age [18] . Because the symptoms of myocarditis are nonspecific, myocardial biopsy is the only means of making the diagnosis [19] . Focal, mild myocarditis may resolve spontaneously, but mortality of fulminant myocarditis is at least 40% in the first 4 weeks and survival rate of patients with untreated giant cell and eosinophilic myocarditis is 20% in 4 years [19] .
If undiagnosed, granulomatous necrotizing myocarditis is fatal [19] . In severe cases, implantation of a ventricular assist device or even heart transplantation may be necessary [20] . Arriving at an early diagnosis is critical since treatment options vary depending on the causative etiology of myocarditis [20] . In acute, chronic and fulminant viral myocarditis, immunosuppression with steroids and intravenous immunoglobulin has been shown to improve outcome [20] . In the rare and often rapidly fatal cases of giant cell myocarditis, where diagnosis is frequently missed until autopsy, initiation of early treatment is critical [21] . Immunosuppressive therapy with triple combination of cyclosporine, azathioprine, and corticosteroids first established in 1990s by
Multicenter GCM study group has remained the choice of treatment to achieve remission defined as survival free of heart transplantation [21, 22] . Viral myocarditis is an important cause of myocarditis in North America and Europe [18] . Histologically, this involves focal myocardial apoptosis, necrosis, macrophage activation and tissue edema [1] . Myocarditis involves three phases, namely acute phase characterized by virus entry, subacute phase involving B and T lymphocyte activation and lastly the chronic phase of myocardial remodeling and development of dilated cardiomyopathy [23] . Although endomyocardial biopsy revealing infiltrative lymphocytes and myocytolysis is considered the gold standard, it is limited in sensitivity and specificity [18] .
Since there are no specific features of myocarditis on echocardiography, 2D echo is mainly used to rule out other causes of heart failure such as valvular, congenital or pericardial cardiovascular disease [24] . LV systolic dysfunction is commonly seen in myocarditis; however, RV systolic dysfunction is the most important predictor of death [24] . Furthermore, echocardiography can be used to identify acute versus fulminant myocarditis.
Acute myocarditis presents with LV dilation, decreased LV function, and normal LV thickness, whereas in fulminant myocarditis LV is not dilated, but is thickened and hypocontractile [25] .
The inflammatory pathophysiology underlying myocarditis may be depicted as increased metabolic activity on PET-CT [7] . Myocardial FDG uptake may vary depending on the cause of myocarditis [7] . For example, radiation and chemotherapy are believed to cause microvascular damage leading to impaired perfusion and fatty acid metabolism necessitating switch to high glucose metabolism [22] [23] [24] [25] [26] . This may lead to regional or uniform global myocardial involvement [7] .
Myocardial inflammation from viral infection
(chronic Epstein-Barr virus) may result in increased heterogeneous FDG uptake [27] .
Exposure to anthracyclines causes myocardial necrosis also leading to abnormal FDG uptake in the myocardium [6, 7] .
Cardiac MR is the most accurate noninvasive imaging modality to diagnose myocarditis with sensitivity and specificity of 100% first reported
by Gagliardi et al. [28] in a cohort of 75 pediatric patients, and reproduced thereafter in other studies with similar results in adults with myocarditis [25] . In the acute and subacute phases, gadolinium-enhanced doubleinversion-recovery fast-spin-echo (DIR-FSE) T2-and T1-weighted images show areas of enhancement in the epicardial regions of the left ventricle, septum, and right ventricle [1, 29] . Increased signal intensity is seen for up to 4 weeks after inflammation has begun [1] .
Delayed gadolinium enhancement imaging is useful in acute phase of myocarditis before irreversible damage has occurred or in the chronic phase where fibrotic changes have taken place [1] . Hyperenhancing nodules and transmural involvement are common with subepicardial, centromyocardial or mixed myocardial enhancement [30] .
Sarcoidosis
Sarcoidosis is a systemic granulomatous disease of unknown etiology [31] . Although only 5% of cases involve the heart, patients may present with acute cardiac failure, arrhythmias or sudden death [31] . Cardiac sarcoidosis has three histologic phases: edema, granulomatous infiltration, and fibrosis and eventual scarring [32] . Usually involvement is predominantly myocardial affecting the LV free wall, basal septum, right ventricle, and finally the atrial wall [1, 31] . This predisposition is believed to be due to increased myocardial mass in these areas [31] .
Standard diagnostic criteria for cardiac sarcoidosis developed by the Japanese Ministry of Health and Welfare lack sensitivity and specificity in the absence of diagnostic myocardial biopsy (Table 2 ) [33, 34] . Even though the gold standard of diagnosis is myocardial biopsy, it has limited utility due to its invasive nature and high false-negative rate secondary to patchy cardiac infiltration [35] .
In its early stages, cardiac sarcoidosis is usually clinically silent, rapidly progressing to heart failure, arrhythmias, and even sudden cardiac death [36] . Currently, there are no [39, 40] . However, myocardial abnormalities earlier on in the disease progression cannot be appreciated on 2D echo.
On
PET-CT, active necrotizing granulomatous disease shows up as increased 18F-FDG uptake in myocardium with nonperivascular distribution [1, 41] . This is a particularly useful imaging modality to identify early stages of disease where inflammatory activity is high but myocardial damage is not yet evident. Also, combined imaging of myocardial perfusion (using TI or 99m Tc SPECT, rubidium-82 or N-13 ammonia PET) and FDG imaging can help differentiate myocardial scar from active myocardial sarcoidosis, and identify various stages of the disease process (Fig. 3 ) [42] . In a study of 22 patients with systemic sarcoidosis, PET-CT had a reported sensitivity and specificity of 100% and 95.5% for diagnosing cardiac sarcoidosis [41] . Since many patients with sarcoidosis require cardiac pacemakers or defibrillators to manage arrhythmias (a contraindication to MR imaging prior to the recent introduction of MRI compatible devices), PET-CT becomes the preferred imaging modality to monitor the disease over time in these patients [7] . CMRI has been shown to be a cost-effective diagnostic technique in evaluating cardiac involvement in sarcoidosis and response to therapy [34] . In a series of 58 patients with biopsy-proven pulmonary sarcoidosis who were being assessed for cardiac sarcoidosis, the sensitivity and specificity of CMRI were 100% and 78%, respectively [34] . On DIR-FSE T2-weighted imaging, the initial edematous phase is seen as localized enhancement of signal intensity and area of hyperintensity within myocardium [1, 35] . Active inflammation appears as delayed enhancement on inversion recovery prepared gradient-echo T1-weighted images [34] and as a focus on cine imaging and bright on DIR-FSE T2-weighted imaging [1] . Scarred segments
show up as gadolinium enhanced segments with regional loss of wall thickness and hypokinesis [1, 34] .
The major findings of amyloidosis, myocarditis and sarcoidosis with echocardiography, FDG-PET-CT, and cardiac MRI are summarized in 
CASE WORKUP
Given the patient's gender, age, and symptoms, the patient had intermediate pretest probability
for CAD and cardiac catheterization was an acceptable diagnostic approach [43] . With the normal coronary angiography, our suspicion for infiltrative cardiomyopathy was high. RV endomyocardial biopsy demonstrated mild focal myocyte hypertrophy and mild focal interstitial fibrosis with no evidence of active myocarditis, granulomatous inflammation, acute or recent myocardial infarction, amyloid heart disease, or iron deposition. However, since endomyocardial biopsy has a high falsenegative rate in cardiac sarcoidosis (due to the focal disease process), we used cardiac MRI and PET-CT to further characterize the pathology due to their high sensitivity for detecting infiltrative and inflammatory cardiomyopathies (Table 4) [12, 22, 29, 35, 41] .
Given the reduced LV EF, patient's symptoms and discordant evaluation from cardiac catheterization, patient met appropriate criteria for use of delayed enhancement and CMRI [44] . CMRI showed akinesis of the basal inferolateral walls with corresponding delayed At follow-up 1 year later, the patient was doing well-with no chest pain, shortness of breath, and no skin, ocular or joint manifestations of sarcoidosis. The patient had normal lung function and now met criteria of New York Heart Association class I (NYHA class I) heart function with no fatigue, palpitations, or dyspnea and otherwise no limitation of physical activity [45] . Given the significant reduction in risk of ICD shock therapy with class III antiarrhythmics versus beta-blockers [46] , the recommendation by the electrophysiologist was to initiate sotalol.
Repeat imaging with FDG-PET-CT rubidium-82 showed unchanged area of medium-sized focal 
CONCLUSION
The case of a 43-year-old male with nonspecific symptoms of palpitations and left ventricular systolic dysfunction is presented here; the initial workup with echocardiography, exercise stress test, and coronary angiography were nondiagnostic. Given a high suspicion for infiltrative cardiomyopathy, CMRI was used to characterize cardiac wall motion abnormalities, FDG-PET-CT and subsequent cardiac and lymph node biopsies were performed to confirm the diagnosis of cardiac sarcoidosis.
Brief etiologies of two other common cardiomyopathies, namely amyloidosis and Uptake is shown in the corresponding segments in alternate rows shown as short axis, horizontal long axis and vertical long axis images. There is a small-to-medium sized perfusion defect involving, the basal inferior wall, basal and mid inferolateral walls. The basal inferior and inferolateral walls show mild mismatch (rest perfusion defect with minimal FDG uptake). There is also increased FDG uptake without a perfusion defect in the regions of the mid-lateral wall, the basal anteroseptal, anterior, and anterolateral walls computed tomography radionuclide imaging, and magnetic resonance imaging in working up these cardiomyopathies were discussed and current algorithms, which are helpful to establish a definitive diagnosis, were also described.
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